Assay of Glycogen Phosphorylase Isoenzyme BB and Its Significance of Diagnosis of Ischemic Myocardial Injury

HUANG Rong-chong,ZHANG Jia-Ning,ZHOU Xu-chen,FANG Wei-yi,ZHU Zheng-mei

DOI: https://doi.org/10.3969/j.issn.1671-7295.2005.03.001

2005-01-01

Abstract:[Objective] To establish a method of glycogen phosphorylase isozymes (GPBB) mass measurement and evaluate GPBB as a cardiac mark during the early diagnosis of acute myocardial infarction(AMI) and unsta- ble angina pectoris(UAP). [Methods] GPBB and its antibody were purified. Establish a developed ELISA assay using polycolonal antibody. The mass of GPBB, the activity of CK, CKMB and cTnI in the serum obtained from 34 normal individuals, 14 stable angina pectoris patients, 28 UAP patients and 29 AMI patients were de- termined by ELISA, respectively. [Results] GPBB was purified 100 times with a resulting specific activity of 384 units per mg protein and with a 28% recovery. The calibration curve of the GPBB in serum is linear throughout 0.3 to 20μg/L. GPBB in 26 AMI patients increased above 7.4μg/L (URL) within the first 6h af- ter AMI onset. The sensitivity of GPBB detected was 89.7%, which was higher than that of CK (24.1%,P 0.01) and CKMB (20.8%,P0.01), equal to that of cTnI. The peak value of GPBB in AMI patients (66.38±27.41)μg/L was significantly higher (P0.01) than that in normal individuals (2.57±1.61)μg/ L. GPBB in 21 out of 28 UAP patients increased above 7.4μg/L (URL) after chest pain onset. The peak value of GPBB in UAP patients (23.2±14.2)μg/L was significantly higher (P0.01) than that in normal individ- uals (2.57±1.61)μg/L and stable angina (2.78±0.94)μg/L. No significant difference was found in serum CK and CK-MB among the 28 UAP patients. GPBB in 21 out of 28 UAP patients increased above 7.4μg/L (URL) after chest pain onset. No significant difference was found in serum CK and CK-MB among UAP and stable angina groups. Among the 28 UAP patients, the incidences of cardiac events within four weeks were sig- nificantly higher in group II(GPBB7.4μg/L) than in group I (GPBB7.4μg/L ) (47.6% vs 14.3%,P 0.01). The time to the peak value of GPBB in patients with AMI was earlier than that of CK and CKMB. [Conclusion] GPBB is more sensitive than CK and CKMB in the patients within 6h after AMI onset. It is also a very useful cardiac mark in early diagnosis of AMI and UAP.